EA200501677A2 - PHOSPHONETIC CONTAINING CONNECTIONS (OPTIONS), PHARMACEUTICAL COMPOSITION (OPTIONS) AND DRUG FORM ON THEIR BASIS, METHOD OF TREATING CANCER (OPTIONS) AND METHOD OF PRESENTING THE CANCER OF OPERATORS - Google Patents
PHOSPHONETIC CONTAINING CONNECTIONS (OPTIONS), PHARMACEUTICAL COMPOSITION (OPTIONS) AND DRUG FORM ON THEIR BASIS, METHOD OF TREATING CANCER (OPTIONS) AND METHOD OF PRESENTING THE CANCER OF OPERATORSInfo
- Publication number
- EA200501677A2 EA200501677A2 EA200501677A EA200501677A EA200501677A2 EA 200501677 A2 EA200501677 A2 EA 200501677A2 EA 200501677 A EA200501677 A EA 200501677A EA 200501677 A EA200501677 A EA 200501677A EA 200501677 A2 EA200501677 A2 EA 200501677A2
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- options
- cancer
- phosphonetic
- operators
- presenting
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к фосфорзамещенным противораковым соединениям, к композициям, содержащим такие соединения, и к терапевтическим способам, включающим введение таких соединений, а также к способам и промежуточным производным, использованным для получения таких соединений.The present invention relates to phosphorus-substituted anticancer compounds, to compositions containing such compounds, and to therapeutic methods including the administration of such compounds, as well as to the methods and intermediate derivatives used to prepare such compounds.
Applications Claiming Priority (124)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46546703P | 2003-04-25 | 2003-04-25 | |
US46558603P | 2003-04-25 | 2003-04-25 | |
US46584403P | 2003-04-25 | 2003-04-25 | |
US46554503P | 2003-04-25 | 2003-04-25 | |
US46532503P | 2003-04-25 | 2003-04-25 | |
US46534303P | 2003-04-25 | 2003-04-25 | |
US46556703P | 2003-04-25 | 2003-04-25 | |
US46537703P | 2003-04-25 | 2003-04-25 | |
US46560703P | 2003-04-25 | 2003-04-25 | |
US46557503P | 2003-04-25 | 2003-04-25 | |
US46558803P | 2003-04-25 | 2003-04-25 | |
US46546503P | 2003-04-25 | 2003-04-25 | |
US46571403P | 2003-04-25 | 2003-04-25 | |
US46547103P | 2003-04-25 | 2003-04-25 | |
US46563103P | 2003-04-25 | 2003-04-25 | |
US46541503P | 2003-04-25 | 2003-04-25 | |
US46560303P | 2003-04-25 | 2003-04-25 | |
US46539403P | 2003-04-25 | 2003-04-25 | |
US46558903P | 2003-04-25 | 2003-04-25 | |
US46564103P | 2003-04-25 | 2003-04-25 | |
US46528703P | 2003-04-25 | 2003-04-25 | |
US46553103P | 2003-04-25 | 2003-04-25 | |
US46533903P | 2003-04-25 | 2003-04-25 | |
US46556903P | 2003-04-25 | 2003-04-25 | |
US46559403P | 2003-04-25 | 2003-04-25 | |
US46555903P | 2003-04-25 | 2003-04-25 | |
US46561403P | 2003-04-25 | 2003-04-25 | |
US46566803P | 2003-04-25 | 2003-04-25 | |
US49330303P | 2003-08-07 | 2003-08-07 | |
US49331003P | 2003-08-07 | 2003-08-07 | |
US49542603P | 2003-08-15 | 2003-08-15 | |
US49542503P | 2003-08-15 | 2003-08-15 | |
US49568503P | 2003-08-15 | 2003-08-15 | |
US49576903P | 2003-08-15 | 2003-08-15 | |
US49566903P | 2003-08-15 | 2003-08-15 | |
US49529703P | 2003-08-15 | 2003-08-15 | |
US49568603P | 2003-08-15 | 2003-08-15 | |
US49541603P | 2003-08-15 | 2003-08-15 | |
US49556503P | 2003-08-15 | 2003-08-15 | |
US49538703P | 2003-08-15 | 2003-08-15 | |
US49552403P | 2003-08-15 | 2003-08-15 | |
US49562903P | 2003-08-15 | 2003-08-15 | |
US49538203P | 2003-08-15 | 2003-08-15 | |
US49552703P | 2003-08-15 | 2003-08-15 | |
US49578903P | 2003-08-15 | 2003-08-15 | |
US49573603P | 2003-08-15 | 2003-08-15 | |
US49533903P | 2003-08-15 | 2003-08-15 | |
US49568203P | 2003-08-15 | 2003-08-15 | |
US49564503P | 2003-08-15 | 2003-08-15 | |
US49539303P | 2003-08-15 | 2003-08-15 | |
US49575103P | 2003-08-15 | 2003-08-15 | |
US49536203P | 2003-08-15 | 2003-08-15 | |
US49553403P | 2003-08-15 | 2003-08-15 | |
US49548403P | 2003-08-15 | 2003-08-15 | |
US49564403P | 2003-08-15 | 2003-08-15 | |
US49578403P | 2003-08-15 | 2003-08-15 | |
US49564703P | 2003-08-15 | 2003-08-15 | |
US49552503P | 2003-08-15 | 2003-08-15 | |
US51394903P | 2003-10-24 | 2003-10-24 | |
US51432503P | 2003-10-24 | 2003-10-24 | |
US51408403P | 2003-10-24 | 2003-10-24 | |
US51411203P | 2003-10-24 | 2003-10-24 | |
US51429803P | 2003-10-24 | 2003-10-24 | |
US51436903P | 2003-10-24 | 2003-10-24 | |
US51443903P | 2003-10-24 | 2003-10-24 | |
US51425803P | 2003-10-24 | 2003-10-24 | |
US51392303P | 2003-10-24 | 2003-10-24 | |
US51397203P | 2003-10-24 | 2003-10-24 | |
US51394803P | 2003-10-24 | 2003-10-24 | |
US51408303P | 2003-10-24 | 2003-10-24 | |
US51396803P | 2003-10-24 | 2003-10-24 | |
US51446203P | 2003-10-24 | 2003-10-24 | |
US51392603P | 2003-10-24 | 2003-10-24 | |
US51442403P | 2003-10-24 | 2003-10-24 | |
US51397103P | 2003-10-24 | 2003-10-24 | |
US51430403P | 2003-10-24 | 2003-10-24 | |
US51411503P | 2003-10-24 | 2003-10-24 | |
US51395603P | 2003-10-24 | 2003-10-24 | |
US51411303P | 2003-10-24 | 2003-10-24 | |
US51356203P | 2003-10-24 | 2003-10-24 | |
US51416103P | 2003-10-24 | 2003-10-24 | |
US51435903P | 2003-10-24 | 2003-10-24 | |
US51356403P | 2003-10-24 | 2003-10-24 | |
US51411403P | 2003-10-24 | 2003-10-24 | |
US51394403P | 2003-10-24 | 2003-10-24 | |
US51392703P | 2003-10-24 | 2003-10-24 | |
US51436803P | 2003-10-24 | 2003-10-24 | |
US51428003P | 2003-10-24 | 2003-10-24 | |
US51448103P | 2003-10-24 | 2003-10-24 | |
US51423503P | 2003-10-24 | 2003-10-24 | |
US51397403P | 2003-10-24 | 2003-10-24 | |
US51420703P | 2003-10-24 | 2003-10-24 | |
US51410503P | 2003-10-24 | 2003-10-24 | |
US51439303P | 2003-10-24 | 2003-10-24 | |
US51439403P | 2003-10-24 | 2003-10-24 | |
US51446103P | 2003-10-24 | 2003-10-24 | |
US51413103P | 2003-10-24 | 2003-10-24 | |
US51392503P | 2003-10-24 | 2003-10-24 | |
US51445203P | 2003-10-24 | 2003-10-24 | |
US51397903P | 2003-10-24 | 2003-10-24 | |
US51414503P | 2003-10-24 | 2003-10-24 | |
US51414403P | 2003-10-24 | 2003-10-24 | |
US51398003P | 2003-10-24 | 2003-10-24 | |
US51434603P | 2003-10-24 | 2003-10-24 | |
US51410803P | 2003-10-24 | 2003-10-24 | |
US51393203P | 2003-10-24 | 2003-10-24 | |
US51396303P | 2003-10-24 | 2003-10-24 | |
US51434503P | 2003-10-24 | 2003-10-24 | |
US51433003P | 2003-10-24 | 2003-10-24 | |
US51420203P | 2003-10-24 | 2003-10-24 | |
US51358803P | 2003-10-24 | 2003-10-24 | |
US51415903P | 2003-10-24 | 2003-10-24 | |
US51396903P | 2003-10-24 | 2003-10-24 | |
US51424703P | 2003-10-24 | 2003-10-24 | |
US51947603P | 2003-11-12 | 2003-11-12 | |
US53194003P | 2003-12-22 | 2003-12-22 | |
US53223003P | 2003-12-22 | 2003-12-22 | |
US53216003P | 2003-12-22 | 2003-12-22 | |
US53259103P | 2003-12-23 | 2003-12-23 | |
US53605404P | 2004-01-12 | 2004-01-12 | |
US53600504P | 2004-01-12 | 2004-01-12 | |
US53600604P | 2004-01-12 | 2004-01-12 | |
US53600704P | 2004-01-12 | 2004-01-12 | |
PCT/US2004/013121 WO2004096235A2 (en) | 2003-04-25 | 2004-04-26 | Anti-cancer phosphonate analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200501677A2 true EA200501677A2 (en) | 2006-04-28 |
Family
ID=59280991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200501677A EA200501677A2 (en) | 2003-04-25 | 2004-04-26 | PHOSPHONETIC CONTAINING CONNECTIONS (OPTIONS), PHARMACEUTICAL COMPOSITION (OPTIONS) AND DRUG FORM ON THEIR BASIS, METHOD OF TREATING CANCER (OPTIONS) AND METHOD OF PRESENTING THE CANCER OF OPERATORS |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA200501677A2 (en) |
-
2004
- 2004-04-26 EA EA200501677A patent/EA200501677A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200501676A1 (en) | PHOSPHONATE-CONTAINING KINASE INHIBITORS (OPTIONS), METHOD FOR THEIR RECEIVING, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL FORM ON THEIR BASIS AND METHOD FOR INHIBING KINASE IN MOLOPYTIC TREATMENT THEM | |
EA200700362A1 (en) | CONJUGAT, CONTAINING ANTI-VIRUS COMPOUND, IN PARTICULAR INHIBITING HIV, PHARMACEUTICAL COMPOSITION AND SET OF STANDARD DOSE OF THE MEDICINAL DRUG ON ITS BASIS, METHOD OF INHIBITING THE SOFTWARE PRO. | |
CY1116373T1 (en) | PHARMACEUTICAL PARTICLES CONTAINING METHYLNALTREXON | |
ATE472551T1 (en) | TOCOPHEROL MODIFIED THERAPEUTIC DRUG COMPOUND | |
CY1112376T1 (en) | 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists | |
BRPI0406801A (en) | Thieno-pyrimidinedione derivatives and their use in modulating autoimmune diseases | |
EA200602191A1 (en) | 5.5-DESIGNED-2-AMINO-4-THIAZOLIDINONES AND METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | |
MA27880A1 (en) | TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | |
EA200300776A1 (en) | FENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES | |
EA200700501A1 (en) | COMPOSITION (OPTIONS) AND METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE PROCESSES, METHOD OF TREATING CANCER (OPTIONS) AND METHOD OF OBTAINING SOLID DISPERSION OF THE SUBSTANCE | |
IS2114B (en) | Quinazoline derivatives to treat tumors | |
EA200401526A1 (en) | NEW CONNECTIONS AND THEIR APPLICATION | |
EA200601212A1 (en) | PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION | |
MA27093A1 (en) | SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS. | |
TW200510392A (en) | Chemical compounds | |
IS6558A (en) | Mixed disease treatment with vasoconstrictor | |
ES2328496T3 (en) | 1,4,8-TRIAZA-ESPIRO (4,5) DECAN-2-ONA SUBSTITUTED COMPOUNDS. | |
EA200501868A1 (en) | TRICYCLIC δ-OPIOID MODULATORS | |
SE0302139D0 (en) | Novel compounds | |
TW200505452A (en) | Chemical compounds | |
SE0402925D0 (en) | Novel Compounds | |
EA200401250A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON MICROPARTICLES FOR INTRA-CANCER INTRODUCTION | |
EA200501821A1 (en) | PHARMACEUTICAL COMBINATION, CONTAINING MODAFINIL AND OTHER DRUG PREPARATION | |
SE0300456D0 (en) | Novel compounds | |
ATE353650T1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF CANCER |